Contrast Enhanced MRI of the CNS - Patients With Known Cerebral Neoplastic Lesions.

Status:
Completed

Trial end date:
2009-05-01

Target enrollment:

Participant gender:

Study to compare of two contrast agents in imaging brain lesions.

Phase 4

Bayer